A case of parathyroid carcinoma visualized on Tc-99m-sestamibi scintigraphy.
Recent studies indicate that Tc-99m-Sestamibi (MIBI, DuPont Pharma) is a useful tracer for detecting parathyroid adenomas. We present a patient with focal Tc-99m-MIBI uptake in parathyroid carcinoma which has only been described once before (1). Tc-99m-MIBI scintigraphy may be considered for diagnosing pathological parathyroid tissue. But presently the histopathological examination only allows the differentiation between adenoma and carcinoma.
Aigner
R M
RM
Department of Radiology, Karl-Franzens-University of Graz, Austria.
Fueger
G F
GF
Lax
S
S
D000368:Aged; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D010282:Parathyroid Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology / Q000601:surgery; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics; D017256:Technetium Tc 99m Sestamibi / Q000493:pharmacokinetics; D013961:Thyroid Gland / Q000000981:diagnostic imaging; D014463:Ultrasonography
D019275:Radiopharmaceuticals; D017256:Technetium Tc 99m Sestamibi